LOGIN
COA 2020: Effect of Liposomal Bupivacaine vs Ropivacaine in Interscalene Block for TSA patients
July 2020
COA 2020: Effect of Liposomal Bupivacaine vs Ropivacaine in Interscalene Block for TSA patients
Study Type:Retrospective Study
OE Level Evidence:N/A
Journal Level of Evidence:N/A
A Comparison of Liposomal Bupivacaine to Standard Ropivacaine Used in Interscalene Blocks for Patients Undergoing Total Shoulder Arthroplasty and the Effect on Postoperative Analgesia, Length of Hospitalization, and Functionality (COA HSP25)
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
One hundred and fifty-six patients undergoing total shoulder arthroplasty were included in this study comparing interscalene brachial plexus blockade with liposomal bupivacaine and ropivacaine or ropivacaine alone. Data was obtained from surgeries performed between June 1st 2017 and September 1st 2019. Outcomes of interest included post-operative pain scores, opioid consumption, length of hospital...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.